Drug intelligence / Profile preview

Fe-HD + TDNV

Development stage: Preclinical
Modality: Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

Fe-HD + TDNV is a combination hydrogel system designed for antibacterial and skin barrier applications. The formulation consists of an iron-based (Fe) hyaluronic acid hydrogel (Fe-HD) integrated with tea-derived nanovesicles (TDNV). This composite material exhibits mild photothermal antibacterial activity, enhances skin hydration, and reduces epidermal thickness. The mechanism involves the synergistic effects of the iron-hyaluronic acid matrix providing structural support and controlled release, while the tea-derived nanovesicles contribute bioactive molecules that promote skin repair and antimicrobial action. The product has demonstrated efficacy in maintaining better skin barrier conditions in preclinical models[5][7].

Other names: Fe‐HD@TDNV hydrogel

Beyond the preview

Go deeper on Fe-HD + TDNV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fe-HD + TDNV.

Explore the full profile